CMS Extends Oncology Demo, Shifts Focus To Clinical Guideline Adherence
Executive Summary
The Centers for Medicare & Medicaid Services is revising its cancer "quality of care" demonstration project to evaluate oncologists' adherence to evidence-based practice guidelines
You may also be interested in...
Labeling Is Critical As Bump From Compendia Listing Diminishes – Genentech
Listing off-label uses in compendia may no longer provide the same bump in sales that would have been seen in the past, Genentech Exec VP - Commercial Operations Ian Clark said
Labeling Is Critical As Bump From Compendia Listing Diminishes – Genentech
Listing off-label uses in compendia may no longer provide the same bump in sales that would have been seen in the past, Genentech Exec VP - Commercial Operations Ian Clark said
Biotech Drugs Will Face Competitive And Reimbursement Pressure – Analysts
Increasing competition could negatively impact market potential for biotech products, Merrill Lynch's David Munno suggested